Evidence map›Paper›PMID 27942020›Full record

ArticlePloS one2016

Evolutionary and Functional Diversification of the Vitamin D Receptor-Lithocholic Acid Partnership.

Erin M Kollitz, Guozhu Zhang, Mary Beth Hawkins, G Kerr Whitfield, David M Reif, Seth W Kullman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Role of vitamin D receptor in the regulation ofActa pharmaceutica Sinica. B · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Erin M KollitzToxicology Program, Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.ORCID http://orcid.org/0000-0003-1769-1496
Guozhu ZhangBioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America.
Mary Beth HawkinsDepartment of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.
G Kerr WhitfieldDepartment of Basic Medical Sciences, The University of Arizona College of Medicine, Phoenix, Arizona, United States of America.
David M ReifBioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, United States of America.
Seth W KullmanToxicology Program, Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, United States of America.
North Carolina State University · USUniversity of Arizona · US

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Andrew R. Binder · 2015 to 2026
$18.3M
GRADUATE TRAINING IN BIOINFORMATICST32ES007329 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Fred A. Wright · 2000 to 2026
$6.8M
TRAINING IN BIOCHEMICAL AND ENVIRONMENTAL TOXICOLOGYT32ES007046 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Seth William Kullman · 1985 to 2026
$5.1M
NIEHS NIH HHS P30 ES025128NIEHS NIH HHS T32 ES007046NIEHS NIH HHS T32 ES007329
6 · The paper itself

Abstract

The evolution, molecular behavior, and physiological function of nuclear receptors are of particular interest given their diverse roles in regulating essential biological processes. The vitamin D receptor (VDR) is well known for its canonical roles in calcium homeostasis and skeletal maintenance. Additionally, VDR has received an increased amount of attention due to the discovery of numerous non-calcemic functions, including the detoxification of lithocholic acid. Lithocholic acid is a toxic metabolite of chenodeoxycholic acid, a primary bile acid. The partnership between the VDR and lithocholic acid has been hypothesized to be a recent adaptation that evolved to mediate the detoxification and elimination of lithocholic acid from the gut. This partnership is speculated to be limited to higher vertebrates (birds and mammals), as lower vertebrates do not synthesize the parent compound of lithocholic acid. However, the molecular functions associated with the observed insensitivity of basal VDRs to lithocholic acid have not been explored. Here we characterize canonical nuclear receptor functions of VDRs from select species representing key nodes in vertebrate evolution and span a range of bile salt phenotypes. Competitive ligand binding assays revealed that the receptor's affinity for lithocholic acid is highly conserved across species, suggesting that lithocholic acid affinity is an ancient and non-adaptive trait. However, transient transactivation assays revealed that lithocholic acid-mediated VDR activation might have evolved more recently, as the non-mammalian receptors did not respond to lithocholic acid unless exogenous coactivator proteins were co-expressed. Subsequent functional assays indicated that differential lithocholic acid-mediated receptor activation is potentially driven by differential protein-protein interactions between VDR and nuclear receptor coregulator proteins. We hypothesize that the vitamin D receptor-lithocholic acid partnership evolved as a by-product of natural selection on the ligand-receptor partnership between the vitamin D receptor and the native VDR ligand: 1α,25-dihydroxyvitamin D3, the biologically active metabolite of vitamin D3.

Indexed as

Biological EvolutionAnimalsHep G2 CellsHumansLithocholic AcidReceptors, CalcitriolVertebratesLithocholic AcidReceptors, CalcitriolVDR protein, human

Identifiers

PMID27942020
PMCPMC5152921
OpenAlexW2563732985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.